Arain Salman J, Morrell Adam H
Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Ultrasound. 2025 May 6:1742271X251337256. doi: 10.1177/1742271X251337256.
Renal transplantation stands as the gold standard treatment for end-stage renal disease, offering improved quality of life and increased survival compared to dialysis. However, despite its advantages, renal allograft failure can occur, necessitating careful management to mitigate associated complications. Instances of liquefaction of the transplanted kidney are exceedingly rare, posing unique challenges to clinicians in the management of allograft failure. Existing literature highlights the complexities surrounding decisions regarding dialysis reinitiation, immunosuppression management, and the potential need for transplant nephrectomy in patients with failed renal allografts.
A 52-year-old Caucasian female with a complex medical history including stage 5 chronic kidney disease, non-ST-segment elevation myocardial infarction, hypertrophic cardiomyopathy with mild left ventricular systolic dysfunction, atrial fibrillation, and a history of cardiac arrest resulting in hypoxic brain injury, presented with a unique complication following renal transplantation. Imaging studies revealed complete breakdown and liquefaction of the transplanted kidney in the right iliac fossa. Despite interventions such as ultrasound-guided aspiration and drainage, the patient's condition continued to deteriorate.
This case highlights a rare occurrence of allograft liquefaction following renal transplantation, emphasising the need for vigilance in monitoring transplant recipients for uncommon complications. The management of such cases requires a multidisciplinary approach, considering factors such as dialysis reinitiation timing, immunosuppression management, and the potential need for transplant nephrectomy. Further research is warranted to elucidate the pathophysiology and optimal management strategies for unique complications such as allograft liquefaction, underscoring the importance of individualised treatment approaches in complex clinical scenarios.
肾移植是终末期肾病的金标准治疗方法,与透析相比,可提高生活质量并延长生存期。然而,尽管肾移植有诸多优势,但仍可能发生移植肾失败,因此需要谨慎管理以减轻相关并发症。移植肾液化的情况极为罕见,给临床医生处理移植肾失败带来了独特挑战。现有文献强调了在肾移植失败患者中重新开始透析、免疫抑制管理以及可能需要进行移植肾切除等决策的复杂性。
一名52岁的白种女性,有复杂的病史,包括5期慢性肾病、非ST段抬高型心肌梗死、伴有轻度左心室收缩功能障碍的肥厚型心肌病、心房颤动以及因心脏骤停导致缺氧性脑损伤的病史,肾移植后出现了一种独特的并发症。影像学检查显示右髂窝的移植肾完全分解并液化。尽管进行了超声引导下的抽吸和引流等干预措施,但患者的病情仍继续恶化。
本病例突出了肾移植后罕见的移植肾液化情况,强调了对移植受者监测罕见并发症时保持警惕的必要性。此类病例的管理需要多学科方法,要考虑重新开始透析的时机、免疫抑制管理以及可能需要进行移植肾切除等因素。有必要进一步研究以阐明移植肾液化等独特并发症的病理生理学和最佳管理策略,强调在复杂临床情况下个体化治疗方法的重要性。